Role of nitric oxide in myotoxic activity induced by crotoxin in vivo

Toxicon

Volumn 43, Issue 4, 2004, Pages 425-432

  Miyabara, E H ^a   Tostes, R C ^a   Selistre De Araujo H S ^b   Aoki, M S ^a   Moriscot, A S ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO CARLOS   (Brazil)

Author keywords

Crotoxin; Myotoxicity; Nitric oxide; Skeletal muscle injury

Indexed keywords

7 NITROINDAZOLE; ACID PHOSPHATASE; AMINOGUANIDINE; CROTOXIN; INDUCIBLE NITRIC OXIDE SYNTHASE; ISOENZYME; LIQUID NITROGEN; N(G) NITROARGININE METHYL ESTER; NEURONAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; SNAKE VENOM; TOLONIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASSAY; CONTROLLED STUDY; EXPERIMENTAL RAT; FREEZING; IN VIVO STUDY; INTRACELLULAR SPACE; MUSCLE NECROSIS; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; STAINING; STATISTICAL SIGNIFICANCE; TIBIALIS ANTERIOR MUSCLE; TISSUE SECTION; TOXICITY;

ANALYSIS OF VARIANCE; ANIMALS; BRAZIL; CROTALUS; CROTOXIN; GUANIDINES; HISTOLOGICAL TECHNIQUES; INDAZOLES; MUSCLE, SKELETAL; NECROSIS; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; RATS; RATS, WISTAR; SIGNAL TRANSDUCTION;

CROTALUS; CROTALUS DURISSUS TERRIFICUS;

EID: 1642503692     PISSN: 00410101     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxicon.2004.02.012     Document Type: Article

References (46)

1. Aird S.D., Kaiser I.I., Lewis R.V., Kruggel W.G. Rattlesnake presynaptic neurotoxins: primary structure and evolutionary origin of the acidic subunit. Biochemistry. 24:1985;7054-7058.
2. Aird S.D., Kaiser I.I., Lewis R.V., Kruggel W.G. A complete amino acid sequence for the basic subunit of crotoxin. Arch. Biochem. Biophys. 249:1986;296-300.
3. 2-potentiated inducible nitric oxide syntase expression by macrophages requires NF-kB activation. J. Immunol. 164:2000;6359-6365.
4. Bancroft J.D. Enzyme histochemistry. Bancroft J.D., Stevens A. Theory and Practice of Histological Techniques. 1996;391-410 Churchill Livingstone, London.
5. Boczkowski J., Lanone S., Ungureanu-Longrois D., Danialou G., Fournier T., Aubier M. Induction of diaphragmatic nitric oxide synthase after endotoxin administration in rats: role on diaphragmatic contractile dysfunction. J. Clin. Invest. 98:1996;1550-1559.
6. Butcher S.P., Henshall D.C., Teramura Y., Iwasaki K., Sharley J. Neuroprotective actions of FK506 in experimental stroke: in vivo evidence against an antiexcitotoxic mechanism. J. Neurosci. 17:1997;6939-6946.
7. Carpenter S., Karpati G. Pathology of Skeletal Muscle. 1984;Churchill Livingstone, London.
8. 2 gene expression in human hepatoma cells by mediators of the acute phase response. J. Biol. Chem. 1991;266-2647.
9. Dawson T.M., Steiner J.P., Dawson V.L., Dinerman J.L., Uhl G.R., Snyder S.H. Immunosuppressant FK506 enhances phosphorylation of nitric oxide synthase and protects against glutamate neurotoxicity. Proc. Natl Acad. Sci. 90:1993;9808-9812.
10. El-Dwairi Q., Guo Y., Comtois A., Zhu E., Greenwood M.T., Bredt D.S., Hussain S.N. Ontogenesis of nitric oxide synthases in the ventilatory muscles. Am. J. Respir. Cell Mol. Biol. 18:1998;844-859.
11. 2 with the crotoxin inhibitor from Crotalus serum. Eur. J. Biochem. 267:2000;4799-4808.
12. 2 generates the novel lipid mediator lysophosphatidic acid in membrane microvesicles shed from activated cells. Cell. 80:1995;919-927.
13. 2. FEBS Lett. 531:2002;7-11.
14. 2. Annu. Rev. Biochem. 64:1995;653-688.
15. 2 complex. Toxicon. 22:1984;85-98.
16. Gunasekar P.G., Kanthasamy A.G., Borowitz J.L., Isom G.E. NMDA receptor activation produces concurrent generation of nitric oxide and reaction oxygen species: implication for cell death. J. Neurochem. 65:(5):1995;2016-2021.
17. Harris J.B. Phospholipases in snake venoms and their effects on nerve and muscle. Harvey A.L. Snake Toxins. 1991;910129 Pergamon Press, New York, USA.
18. Hendon R.A., Fraenkel-Conrat H. Biological role of the two components of crotoxin. Proc. Natl Acad. Sci. USA. 68:1971;1560-1563.
19. Kapur S., Bedard S., Marcotte B., Cote C.H., Marette A. Expression of nitric oxide synthase in skeletal muscle: a novel role for nitric oxide as a modulator of insulin action. Diabetes. 46:1997;1691-1700.
20. 2. Toxicon. 27:1989;613-635.
21. 2 on cell membranes. Vesicle but not heparinoid binding determines rate of fatty acid release by exogenously added enzyme. J. Biol. Chem. 273:1998;32142-32153.
22. Kouyoumdjian J.A., Harris J.B., Johnson M.A. Muscle necrosis caused by the sub-units of crotoxin. Toxicon. 24:(6):1986;575-583.
23. 2. Biochim. Biophys. Acta. 1170:(3):1993;217-231.
24. 2. Trends Pharmacol. Sci. 20:1999;162-170.
25. 2. J. Biol. Chem. 269:1994;1575-1578.
26. Landucci E.C.T., Condino-Neto A., Perez A.C., Hyslop S., Corrado A.P., Novello J.C., Marangoni S., Oliveira B., Antunes E., de Nucci G. Crotoxin induces aggregation of human washed platelets. Toxicon. 32:1994;217-226.
27. Lotem J., Kama R., Sachs L. Suppression or induction of apoptosis by opposing pathways downstream from calcium-activated calcineurin. Proc. Natl Acad. Sci. USA. 96:1999;12016-12020.
28. Mebs D., Ownby C.L. Myotoxic components of snake venoms: their biochemical and biological activities. Pharm. Ther. 48:1990;223-236.
29. Miyabara E.H., Tostes R.C., Selistre de Araújo H.S., Aoki M.S., Salvini T.F., Moriscot A.S. Cyclosporin A attenuates skeletal muscle damage induced by crotoxin in rats. Toxicon. 43:(1):2004;35-42.
30. Moore P.K., Babbedge R.C., Wallace P., Gaffen Z.A., Hart S.L. 7-nitroindazole, an inhibitor of nitric oxide synthase, exhibits anti-nociceptive activity in the mouse without increasing blood pressure. Br. J. Pharmacol. 108:(2):1993;296-297.
31. Morini C.C., Pereira E.C.L., Selistre de Araújo H.S., Ownby C.L., Salvini T.F. Injury and recovery of fast and slow skeletal muscle fibers affected by ACL myotoxin isolated from Agkistrodon contortrix laticinctus (Broad-Banded Copperhead) venom. Toxicon. 36:(7):1998;1007-1024.
32. Nathan C., Xie Q.W. Nitric oxide synthases: roles, tolls, and controls. Cell. 78:1994;915-918.
33. Okuda S., Kanda F., Kawahara Y., Chihara K. Regulation of inducible nitric oxide synthase expression in L6 rat skeletal muscle cells. Am. J. Physiol. Cell Physiol. 272:1997;C35-C40.
34. Rao V.S., Santos F.A., Silva R.M., Teixiera M.G. Effects of nitric oxide synthase inhibitors and melatonin on the hyperghycemic response to streptozotocin in rats. Vascul. Pharmacol. 38:(3):2002;127-130.
35. Ribeiro M.O., Antunes E., de Nucci G., Lovisolo S.M., Zatz R. Chronic inhibition of nitric oxide synthesis. A new model of arterial hypertension. Hypertension. 20:(3):1992;298-303.
36. Rubinstein I., Abassi Z., Coleman R., Milman F., Winaver J., Better O.S. Involvement of nitric oxide system in experimental muscle crush injury. J. Clin. Invest. 101:1998;1325-1333.
37. Rübsamen K., Breithaupt H., Habermann E. Biochemistry and pharmacology of the crotoxin complex. Naunyn Schmiedeberg's Arch. Pharmacol. 270:1971;274-288.
38. Saito S., Hiroi Y., Zou Y., Aikawa R., Toko H., Shibasaki F., Yazaki Y., Nagai R., Komuro I. β-adrenergic pathway induces apoptosis through calcineurin activation in cardiac myocytes. J. Biol. Chem. 275:2000;34528-34533.
39. Salvini T.F., Morini C.C., Selistre de Araújo H.S., Ownby C.H. Long-term regeneration of fast and slow murine skeletal muscles after induced injury by ACL myotoxin isolated from Agkistrodon contortrix laticinctus (Broad-Banded Copperhead) venom. Anat. Rec. 254:(4):1999;521-533.
40. Sampaio S.C., Sousa-e-Silva M.C.C., Borelli P., Curi R., Cury Y. Crotalus durissus terrificus snake venom regulates macrophage metabolism and function. J. Leukoc. Biol. 70:2001;551-558.
41. Sannomiya P., Oliveira M.A., Fortes Z.B. Aminoguanidine and the prevention of leukocyte dysfunction in diabetes mellitus: a direct vital microscopic study. Br. J. Pharmacol. 122:(5):1997;894-898.
42. Shagger H., Jagow G. Tricine-sodium dodecyl sulfate polyacrylamide gel eletrophoresis for the separation of proteins in the range from 1 to 100 kDa. Analyt. Biochem. 166:1987;368-379.
43. Snyder S.H., Sabatini D.M., Lai M.M., Steiner J.P., Hamilton G.S., Suzdak P.D. Neural actions of immunophilin ligands. TiPS. 19:1998;21-26.
44. Stamler J.S., Meissner G. Physiology of nitric oxide in skeletal muscle. Physiol. Rev. 81:2001;209-237.
45. Thiemermann C., Bowes J., Myint F.P., Vane J.R. Inhibition of the activity of poly (ADP ribose) synthetase reduces ischemia-reperfusion injury in the heart and skeletal muscle. Proc. Natl Acad. Sci. USA. 94:1997;679-683.
46. 2 expression and inflammation: the relationship with associated disease states. J. Lipid Mediat. 8:(1):1993;1-30.